Groupe d'Etude des Tumeurs Digestives

Groupe d'Etude des Tumeurs Digestives
Name	Groupe d'Etude des Tumeurs Digestives
Acronym	GESTD
Formation	20th century
Type	Medical research group
Headquarters	Paris
Region served	France; Europe
Leader title	President

Groupe d'Etude des Tumeurs Digestives is a French clinical and research consortium focused on neoplasms of the gastrointestinal tract, integrating oncology, surgery, radiology, and pathology to improve outcomes for patients with digestive cancers. The group operates within national and international frameworks linking academic centers, teaching hospitals, and specialty societies to coordinate multicenter trials, develop clinical guidelines, and provide subspecialty education.

History

The group's origins trace to postwar oncology reorganizations associated with institutions such as Institut Gustave Roussy, Hôpital Cochin, Hôpital Pitié-Salpêtrière, Institut Curie, and university medical faculties in Paris, Lyon, and Marseille, influenced by figures linked to André Lwoff-era biomedical expansions and collaborations with Commissariat à l'énergie atomique et aux énergies alternatives research networks. Early meetings were convened alongside conferences of Société Française d'Oncologie Médicale, Collège Français des Chirurgiens, and Société Française de Radiothérapie Oncologique, while registry efforts coordinated with regional cancer registries such as Registre du Cancer de la Côte d'Or and international initiatives exemplified by European Society for Medical Oncology workshops. Over decades, the group adapted to regulatory changes prompted by directives from European Medicines Agency, clinical trial frameworks informed by Good Clinical Practice, and funding shifts connected to bodies like Agence Nationale de la Recherche and Institut National du Cancer.

Mission and Objectives

The group's core mission mirrors aims advocated by organizations such as World Health Organization, Union for International Cancer Control, and European Organisation for Research and Treatment of Cancer: to reduce morbidity and mortality from digestive tumors through evidence generation, guideline development, and dissemination to practitioners affiliated with Assistance Publique–Hôpitaux de Paris, university hospitals at Université Paris Cité, and regional cancer centers like Centre Léon Bérard. Objectives include designing randomized studies comparable to trials by National Cancer Institute (United States), creating multidisciplinary pathways akin to protocols from National Comprehensive Cancer Network, and promoting translational research in collaboration with laboratories such as INSERM units and research institutes like CNRS-associated teams.

Organization and Leadership

Governance structures reflect models used by European Cancer Organisation committees and national learned societies such as Société Française d'Endoscopie Digestive, with elected presidencies, scientific steering committees, and subcommittees for sites including esophagus, stomach, pancreas, liver, biliary tract, and colorectal regions. Leadership has included academic surgeons from departments at Hôpital Beaujon, medical oncologists with affiliations to Gustave Roussy, radiologists trained at Hôpital Saint-Louis, and pathologists linked to Collège de Pathologie. Administrative coordination often interfaces with grant offices at INSERM Transfert, ethical review boards such as Comité de Protection des Personnes, and regulatory authorities including ANSM. Advisory relationships draw on experts associated with European Reference Network on Rare Adult Solid Cancers and patient advocacy groups like La Ligue contre le cancer.

Research and Clinical Trials

The group designs trials spanning adjuvant, neoadjuvant, and metastatic settings, sometimes harmonized with multicenter protocols from EORTC and cooperative groups akin to Transatlantic Gastrointestinal Group collaborations. Study themes mirror research priorities of Cancer Research UK and American Society of Clinical Oncology consensus reports: biomarkers, targeted therapies, immunotherapy, surgical techniques, and radiotherapy modalities. Trials have evaluated cytotoxic regimens comparable to those studied in MAGIC trial-informed perioperative chemotherapy, assessed targeted agents similar to trastuzumab studies for HER2-positive gastric cancer, and explored stereotactic approaches paralleling work by American College of Radiology. Data management and biobanking adopt standards promoted by BioBanking and Biomolecular Resources Research Infrastructure and analytic methods used in consortia like The Cancer Genome Atlas.

Publications and Guidelines

The group publishes peer-reviewed reports in journals associated with European Journal of Cancer, Annals of Oncology, Journal of Clinical Oncology, and national outlets such as Bulletin du Cancer, often contributing to guidelines cited alongside documents from NICE, HAS (Haute Autorité de Santé), and ESMO. Recommendations address surgical margins, perioperative regimens, molecular testing for markers like KRAS and MSI, and follow-up protocols reflecting practices established by ASCO guideline panels. Position statements have been presented at meetings of ESMO Congress, ASCO Annual Meeting, Gastric Cancer Symposium, and French specialty congresses including Journées Francophones de Radiothérapie Oncologique.

Education and Training

Educational activities mirror postgraduate programs at institutions such as Université de Strasbourg and Université de Bordeaux, offering fellowships, workshops, and hands-on courses coordinated with societies like Société Française d'Oncologie Médicale and Société Française d'Endoscopie Digestive. Training covers endoscopic techniques taught alongside experts from American Society for Gastrointestinal Endoscopy, surgical oncology modules drawing on curricula from European Board of Surgical Qualification, and pathology seminars akin to those by International Academy of Pathology. The group also hosts symposia attracting delegates from WHO Regional Office for Europe, European School of Oncology, and national medical student associations.

Collaborations and Affiliations

Collaborative links encompass university hospitals, research institutes, national agencies, and international consortia such as EORTC, ESMO, UICC, and EANM for imaging research, with bilateral partnerships involving centers in Belgium, Germany, Spain, Italy, and United Kingdom. Affiliated bodies include INSERM, CNRS, Institut National du Cancer, and patient organizations like Institut Curie Foundation and Association François Aupetit-type groups, fostering translational pipelines similar to networks established by Cancer Research UK and transnational projects funded by European Commission research programs.

Category:Medical research organizations